Skip to main content
Clinical Trials/NCT02426593
NCT02426593CompletedNot Applicable

Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology

Intersection Medical, Inc.1 site in 1 country100 target enrollmentStarted: April 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Data Collection

Study Overview

Brief Summary

This study will be conducted to collect anatomical data in an ambulatory healthy population to aid in the development of a novel non-invasive technology to assess changes in lung hydration status. It will also help in developing reference ranges of lung hydration status in healthy subjects and their associated changes with time.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
30 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Subjects > 30 years of age
  • •Subjects who are ambulatory not requiring assistance for ambulation
  • •Subjects who have been informed of the nature of the study and agree to its provisions and have provided written informed consent as approved by the IRB

Exclusion Criteria

  • •Subjects with an active implantable medical device not cleared for use with the IMED-4 in the IMED- 4 Investigators Brochure.
  • •Subjects who are pregnant or lactating or who have been pregnant within the past three months
  • •Subjects who have a measured temperature of >38° C at the time of screening
  • •Subjects who have tattoos and/or non-intact skin on the back in the electrode patch placement region
  • •Subjects who have had a past serious allergic reaction to adhesives
  • •Patients who decline to have their backs photographed with the IMED-4 device in position
  • •Subjects who have poor general physical/mental health that, in the opinion of the investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, incarceration, shortened life expectance, etc.)

Outcomes

Primary Outcomes

Data Collection

Time Frame: 12 months

The primary endpoint is successful IMED-4 recordings at multiple timepoints from one hundred (100) unique subjects. A recording will be considered successful if it meets IMED-4 recording quality indicators.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials